ABSTRACT An analysis was made of the mechanisms responsible for the increased splenic hemopoiesis occurring in mice after the injection of the bacterial cell wall components lipid A and outer membrane lipoprotein. No evidence was obtained for the presence of functional lipid A receptors on hemopoietic precursor cells. Serum from lipid A-injected mice, on injection into normal mice, induced in tMe spleen an increased content of all hemopoietic progenitor cells. The magnitude of the response was dependent on the dose of lipid A used and the
ABSTRACT An analysis was made of the mechanisms responsible for the increased splenic hemopoiesis occurring in mice after the injection of the bacterial cell wall components lipid A and outer membrane lipoprotein. No evidence was obtained for the presence of functional lipid A receptors on hemopoietic precursor cells. Serum from lipid A-injected mice, on injection into normal mice, induced in tMe spleen an increased content of all hemopoietic progenitor cells. The magnitude of the response was dependent on the dose of lipid A used and the volume of serum transferred to the recipients. C3H/HeJ mice unresponsive to lipid A exhibited similar spleen changes when injected with active post-lipid A sera. Progenitor cells of all hemopoietic lineages, including multipotential hemopoietic stem cells, were involved in the response. The results suggest that a humoral factor mediates the lipid A-induced increase of splenic hemopoiesis.
Bacterial cell-wall components (BCWC) have marked stimulatory effects on hemopoiesis. Bacterial lipopolysaccharide (LPS) increases serum levels in mice of a leukocytosis-inducing factor (1), of two hemopoietic factors-i.e., colony-stimulating factors (CSF)-stimulating colony formation in vitro by progenitor cells (CFC) of neutrophilic granulocytes and macrophages (GM) (2) , and of a factor that potentiates the action of GM CSF in vitro (3, 4) . The most striking changes in hemopoiesis after LPS injection occur in the spleen, which increases in size and shows a marked rise in CFC for neutrophilic granulocytes and macrophages (5) . Lipid A has been identifed as the moiety responsible for both the humoral and cellular responses induced by LPS (6) . Several mechanisms have been postulated to explain the increase in splenic CFC numbers after injection of LPS or similar hemopoiesis-stimulating agents into mice (7) (8) (9) (10) . The most likely explanation appeared to be that the increase in splenic CFC numbers was mediated by the increased serum and tissue CSF levels, which precede the cellular response (5, 11, 12) .
A comparative analysis of the hemopoietic effects of highly purified preparations of three structurally unrelated BCWC showed (13) (14) (15) (16) (17) (18) ) that all three BCWC-i.e., lipid A, the outermembrane lipoprotein, and murein-induced increase of CSF levels in vivo (14, 15, 17) and in vitro (13) . However, increased splenic CFC levels occurred only after injection of lipid A or lipoprotein and not after injection of murein. Furthermore, after injection of lipid A or lipoprotein, all clonable hemopoietic CFC increased in numbers (18) . Rises occurred in eosinophil, megakaryocyte, and erythroid precursors, as well as multipotential hemopoietic stem cells (CFU-S), whereas the splenic numbers of colony-forming cells for B lymphocytes (BL-CFC) remained unaltered (16) . The present experiments were performed to elucidate further the mechanisms by which BCWC induce increased splenic hemopoiesis.
MATERIALS AND METHODS
Mice. Eight-to 12-week-old male and female mice were used in all experiments. C3H/Hej mice were obtained from the Jackson Laboratory. C57BL/6J Wehi and C3H/HeJGif Wehi mice were produced in our own facilities under specific pathogen-free conditions until 8 weeks of age.
Cells. Bone marrow cells were flushed from the femurs of mice with cold sterile Eisen's balanced salt solution. Spleens were passed through stainless steel sieves and single cell suspensions were prepared by gentle pipetting.
Complement-Mediated Cytotoxicity. The IgG fraction of the anti-lipid A receptor serum and the IgG fraction of the corresponding control serum (19, 20) were kindly supplied by A. Coutinho, Basel Institute for Immunology, Basel, Switzerland. A rabbit antiserum to endogenous xenotropic type C virus (21) was kindly provided by C. Moroni, Friedrich-Miescher Institute, Basel, Switzerland. Samples of 2 X 106 viable nucleated C57BL/6 marrow cells in 0.1 ml of RPMI-1640 tissue culture medium (GIBCO) supplemented with 10% fetal calf serum were incubated with 0.1 ml of 1:5-diluted antiserum for 30 min on ice. Pretested, spleen cell-absorbed, rabbit serum was added as a source of complement and the mixture was incubated for 30 min at 37°C. After washing, the samples were tested for CFC and CFU-S as described below.
Agar Cultures. B lymphocyte colonies were grown as described by Metcalf et al. (22) . The culture medium contained 0.05 ml of 60% washed sheep erythrocytes per ml, 4 performed as described (23) (24) (25) . The frequency of tight eosinophil colonies was determined by sequentially removing 60 colonies and placing them onto albumin-coated slides. Air-dried colonies were stained for 1 hr with 0.1% (wt/vol) luxol fast blue stain in 70% (vol/vol) ethanol saturated.with urea. The slides were washed for 1 hr in tap water, counterstained with hematoxylin, and washed again with tap water. Luxol fast bluepositive eosinophil cells displayed a brilliant greenish staining of these granules (unpublished data).
Spleen Colony Assay. The spleen colony assay (26) was performed as described (14) . Recipient mice were irradiated with 800 rads (8 grays) and spleen colony counts were performed on day 7. BCWC. Core-lipid A (lipid A) from Salmonella minnesota R345 and outer membrane lipoprotein and murein from Escherichia colt B were gifts from L. Tarcsay, CIBA-GEIGY, Basel, Switzerland. Their preparation and chemical analysis have been described in detail elsewhere (14) . All injections were made intraperitoneally (i.p.) in an injection volume of 0.5 ml of pyrogen-free saline per mouse. Mice were bled 6 hr later from the orbital plexus while they were under ether anesthesia. had only a small effect on splenic progenitor cell levels ( Table  2) . To further characterize the optimal conditions in this serum transfer system, the relationship between different doses of PLAS injected and the subsequent increase in splenic CFC numbers was studied. C57BL/6 mice were injected i.p. with 0.5 mg per mouse of lipid A and bled 6 hr later. The PLAS was serially diluted with pyrogen-free saline, and 1-ml aliquots of each dilution were injected i.p. into groups of two normal C57BL/6 mice. Control C57BL/6 mice were injected i.p. with different dilutions of normal C57BL/6 mouse serum or 1 ml of pyrogen-free saline. On the sixth day after injection, the pooled spleen cells and some of the femoral marrow cells of the mice of each group were cultured to determine the femoral and splenic hemopoietic CFC levels. Table 3 shows the results of one of two experiments. The splenic progenitor cell content in the control mice varied between 1700 and 7600 CFC. The lowest dose of PLAS that caused an elevation of the splenic progenitor cell numbers above background was the 1:8 dilution. The splenic CFC content increased progressively with increasing doses of PLAS up to the highest dose of PLAS, 1 ml of undiluted serum inducing a 30-fold increase in splenic CFC numbers compared with the highest control value. In com- 4 parison, femoral marrow CFC numbers showed little fluctuation and no consistent difference was observed between the groups analyzed.
RESULTS
Effect of Injecting PLAS from Lipid A High-Responder into Lipid A Non-Responder Mice. The increased number of splenic CFC after PLAS injection could have been due paally or entirely to the presence of residual lipid A in the serum, rather than to a factor produced in the donor mice after lipid A injection. To test this possibility, experiments were performed with lipid A-resistant C3H/HeJ (29) mice, which do not show an increase in splenic CFC numbers after LPS or lipid A injection (12, 14) but do respond to lipoprotein injection (14) . C3H/HeJ mice were injected i.p. with 1 ml of normal C3H/ WEHI serum or 1 ml of C3H/WEHI PLAS (preliminary experiments had shown that C3H/WEHI mice are lipid A high-responder mice-i.e., they show increased serum CSF and splenic CFC levels after lipid A injection). Control C3H/HeJ mice were injected i.p. with either saline or 0.5 mg per mouse of lipid A or lipoprotein. Splenic CFC numbers were determined on the fifth day after injection. The pooled results of three separate experiments are shown in Table 4 (31, 32) . Furthermore, the buoyant density of LPS and lipid A have been observed to change after interaction with rabbit and mouse serum or plasma both in vivo and in vitro (32) , and this density shift is associated with the complete inhibition of important biological activities of LPS and lipid A. Quantification of different hemopoietic precursor cells showed that PLAS caused an increase in the splenic content both of CFU-S and CFC of all hemopoietic lineages. These CFC have been shown to be early descendants of CFU-S (33) (34) (35) . Unpublished experiments indicate that all morphologically identifiable hemopoietic precursor cells increase in the spleen after injection of PLAS. On the basis of this information we postulate that lipid A causes increased hemopoiesis in the spleen by eliciting the production of a specific humoral factor having a selective action on spleen hemopoietic populations. The present data do not eliminate the possibility that the increased splenic content of hemopoietic precursor cells may be due partly to migration of cells from the marrow.
